Vaccine Supply Articles & Analysis
22 news found
Their pioneering research has revolutionized the way we combat infectious diseases and has undoubtedly saved countless lives during the COVID-19 pandemic." In effect, mRNA vaccines have reached the spotlight for a while as a new alternative to conventional vaccines. ...
"End-to-End Support for Your Pharmaceutical Journey", with the commitment to researchers, BOC Sciences will attend the renowned World Vaccine Congress Europe in Barcelona, Spain, from 16 to 19 Octobe World Vaccine Congress Europe has become the world's largest and most established meeting dedicated to vaccines. ...
The featured vaccine products supplied by Alfa Chemistry are listed as below: Nucleic Acid Delivery ExcipientsNucleotide vaccines, including mRNA vaccines with their intracellular antigen synthesis, have been shown to be potent activators of a cytotoxic immune response. ...
The sublingual COVID-19 vaccine uses sublingual mucosal delivery technology to deliver the vaccine to the mucous membrane. ...
Subjects who had a SARS-CoV-2 response prior to vaccination were omitted from efficacy calculations, as this would infer prior infection or vaccination. ...
The World Health Organization (WHO) recently added COVAXIN™ (BBV152) to its list of vaccines authorized for emergency use. And, as many as 110 countries have agreed to mutual recognition of Covid-19 vaccination certificates with India that includes vaccination using COVAXIN™ (BBV152). ...
Located in Genome Valley in Hyderabad, India, a hub for the global biotech industry, Bharat Biotech has built a world-class vaccine & bio-therapeutics, research & product development, Bio-Safety Level 3 manufacturing, and vaccine supply and distribution. Having delivered more than 4 billion doses of vaccines worldwide, ...
The GHC registration will leverage our competitiveness and enable us to enter new markets with promising growth trajectories hereby supporting our objective of a stronger regional foothold”, says Jérôme Cabannes, COO of AJ Vaccines. Strong potential for new business Currently AJ Vaccines supplies BCG Vaccine ...
The World Health Organization (WHO) recently added COVAXIN™ to its list of vaccines authorized for emergency use. And, as many as 110 countries have agreed to mutual recognition of Covid-19 vaccination certificates with India that includes vaccination using COVAXIN™. ...
The World Health Organization (WHO) recently added COVAXIN™ to its list of vaccines authorized for emergency use. And, as many as 110 countries have agreed to mutual recognition of COVID-19 vaccination certificates with India that includes vaccination using COVAXIN™. ...
Ltd., listed stock market company and Germany based ARTES Biotechnology GmbH announce the execution of a Development and License Agreement aiming at the generation of microbial production cell lines, processes and documentation for the cGMP manufacturing of two enzymes required in the manufacturing process of mRNA vaccines. Under this agreement, ARTES shall be responsible for the ...
Currently, due to the severe situation of the COVID-19 pandemic, the global need for vaccines is still huge. Under this circumstance, BOC Sciences has strengthened its supply capacity of pseudoUridine and derivatives to ease the pressure on the global supply of vaccine raw materials. ...
Data will be presented at American Society for Virology (ASV) 2021 and are available on bioRxiv REDWOOD CITY, Calif., July 19, 2021 – Meissa Vaccines (“Meissa”), a biotechnology company developing vaccines to prevent serious viral respiratory infections, announced today the release of preclinical data in nonhuman primates (NHPs) of the ...
Once reconstituted, however, the vaccines exhibit very poor thermal stability and rapidly lose effectiveness if not refrigerated. This is an important consideration in low- and middle-income countries (LMIC) where cold-chain issues and access to target populations for vaccinations can be challenging. By eliminating the need for reconstitution and improving ...
After a fourth dose, administered one year later, antibody levels were boosted to levels similar to the peak titers achieved following the primary series of vaccinations. The Matrix-M component of the malaria vaccine will be manufactured and supplied to SII by Novavax. ...
ByNovavax
Puretech’s AquaZero distillation system was recently supplied to Scotland based contract manufacturing organisation Andersen Caledonia. The system will enable the company to wash glass vials prior to sterile packing in its ISO 5 cleanroom. The vials will then be supplied to be filled with vaccines. The AquaZero Still generates ...
Enesi Pharma recently hosted a crew from Asahi TV, one of Japan’s leading TV channels, at its Oxford, UK facility to talk about the potential of its ImplaVax® solid dose needle-free vaccination technology. The conversation coincided with the approval of the Pfizer/BioNTech COVID-19 vaccine Comirnaty® in Japan and potential dose-wasting issues linked ...
The site will expand the company's clinical and commercial capabilities for cGMP plasmid DNA used as a critical raw material to develop and manufacture cell and gene-based therapies including life-saving cancer treatments as well as mRNA vaccines. In addition, the site will have the capability to produce large-scale plasmid DNA as a primary drug substance for DNA therapies. ...
Thermo Fisher Scientific, the world leader in serving science, today announced it will further expand its footprint in North America and Europe for sterile drug product development and commercial manufacturing of critical medicines, therapies and vaccines. "We have continued to invest strategically in capacity, technology and expertise across our global network so we can ...
Small idea, Big impact: Global Challenge: in response to Covid-19, there have been many examples of innovation, including technology powered by artificial intelligence (AI) to help track the outbreak, clean hospitals, deliver supplies and develop vaccines. Leader of the Year: celebrating an exemplary leader whose vision, passion and strategic thinking has had a ...
